http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-63602-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 1999-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74f11fb17beb893fd79018de1174898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c614ba82bca1d6833d61b5900c2fca0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b33a3ade3355787509887a0514c877 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6557bdf2c2925005082f6878a6a141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a72063d7f1c9bdcf64d4813b6062ddb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c4a3a76bd80e2a65c5ce334bf0fcab0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480f7c54fbd8a192ab8827c550eaa62d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb08bee1a541b294ac6facfb39627b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b9f40ec42275cc5f14f02181959d45 |
| publicationDate | 2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-63602-B1 |
| titleOfInvention | 3-SUBSTITUTED PYRIDO [4 ', 3': 4,5] THIENO [2,3-D] PYRIMIDINE DERIVATIVES, THEIR RECEIVING AND USE |
| abstract | The 3-substituted 3,4,5,6,7,8-hexahydro-pyrido [4 ', 3': 4,5] -thieno [2,3-d] pyrimidine derivatives can be used as medicines for diseases in which have a decreased serotonin concentration and in which the activity of the presynaptic receptors 5-HT1B-, 5-HT1A-, 5-HT1D- without blocking other receptors is strongly impeded during therapy. Depression is an example of such a medical condition. The compounds have the formula wherein R1 is hydrogen, a C1-C4-alkyl group, acetyl, benzoyl, phenylalkyl-C1-C4-moiety, wherein the aromatic moiety is optionally substituted by halogen, C1-C4-alkyl, trifluoromethyl, hydroxy- , A C1-C4-alkoxy, amino, cyano or nitro group or is a naphthalene-C1-C3-alkyl residue, a phenylalkanone-C2-C3-residue, or a phenylcarbamoylalkyl-C2-residue, wherein the phenyl group may be replaced by a halogen; R2 is optionally mono-, di- or tri-substituted with halogen atoms, C1-C4-alkyl, trifluoromethyl, trifluoromethoxy, hydroxy, C1-C4-alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro, phenyl, a pyridyl, pyrimidinyl or pyrazinyl residue which may optionally be annelated with a benzene ring which may optionally be mono- or disubstituted by a halogen atom, C1-C4-alkyl, hydroxy, trifluoromethyl, C1-C4-alkoxy -, amino, cyano or nitro, and optionally may contain one nitrogen atom or be annulled with 5- or 6- a membered ring which may contain one to two oxygen atoms, or |
| priorityDate | 1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.